Kallikrein-Related Peptidase 3(KLK3/PSA) Single Nucleotide Polymorphisms and Ovarian Cancer Survival
- 1 August 2011
- journal article
- Published by Cambridge University Press (CUP) in Twin Research and Human Genetics
- Vol. 14 (4) , 323-327
Abstract
There is substantial evidence suggesting a role for hormone-regulated kallikrein-related peptidases (KLKs) in carcinogenesis and tumour metastasis. KLKs are considered to have potential as prognostic biomarkers for hormone dependent cancers, particularly ovarian cancer. The purpose of this study was to evaluate the association between Kallikrein-related peptidase 3 (KLK3) gene single nucleotide polymorphisms (SNPs) located in hormone response elements and ovarian cancer survival. DNA samples were analyzed from 304 Australian women diagnosed with epithelial ovarian cancer. The KLK3 rs266882 and rs11084033 SNPs were genotyped by the Sequenom iPLEX Mass Array platform. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using Cox regression models. An association was observed with ovarian cancer survival for homozygote carriers of the rare allele of rs11084033 (adjusted HR 2.12, 95% CI 1.08–4.15). This finding is consistent with bioinformatic analysis predicting the rs11084033 rare allele to be responsible for the loss of a confirmed androgen response element, and with published expression data suggesting that aggressive ovarian cancers show decreased KLK3 tumor expression. The rs11084033 has potential prognostic significance in ovarian cancer. However, this finding requires replication, and further investigation regarding the functional significance of rs11084033 and correlated SNPs.Keywords
This publication has 18 references indexed in Scilit:
- Androgens and polycystic ovary syndromeCurrent Opinion in Endocrinology, Diabetes and Obesity, 2009
- Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levelsBritish Journal of Cancer, 2008
- The role of glutathione-S-transferase polymorphisms in ovarian cancer survivalEuropean Journal of Cancer, 2007
- Mutation analysis of five candidate genes in familial breast cancerBreast Cancer Research and Treatment, 2006
- PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibilityCarcinogenesis, 2006
- Human tissue kallikrein gene family: applications in cancerCancer Letters, 2005
- The Tissue Kallikrein Family of Serine Proteases: Functional Roles in Human Disease and Potential as Clinical BiomarkersCritical Reviews in Clinical Laboratory Sciences, 2004
- Dietary influences on survival after ovarian cancerInternational Journal of Cancer, 2003
- A New Statistical Method for Haplotype Reconstruction from Population DataThe American Journal of Human Genetics, 2001
- Cooperative Assembly of Androgen Receptor into a Nucleoprotein Complex That Regulates the Prostate-specific Antigen EnhancerJournal of Biological Chemistry, 1999